National Institute on Drug Abuse Clinical Trials Network Meeting Report: Managing Patients Exposed to Xylazine-Adulterated Opioids in Emergency, Hospital and Addiction Care Settings

This publication has 27 references indexed in Scilit:

• Understanding sensitivity and cross‐reactivity of xylazine lateral flow immunoassay test strips for drug checking applications
  Drug Testing and Analysis, 2023
• An analytical platform for near real-time drug landscape monitoring using paraphernalia residues
  Forensic Chemistry, 2023
• A Neuropharmacological Model to Explain Buprenorphine Induction Challenges
  Annals of Emergency Medicine, 2022
• Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis
  Drug and Alcohol Dependence, 2022
• High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021
  Clinica Chimica Acta, 2021
• Evaluation of dexmedetomidine withdrawal in critically ill adults
  Journal of Critical Care, 2021
• Protracted renal clearance of fentanyl in persons with opioid use disorder
  Drug and Alcohol Dependence, 2020
• Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature
  Forensic Science International, 2014
• Abrupt Discontinuation of Clonidine Therapy
  JAMA, 1979
• Evidence for increased vagal tone and enhancement of baroreceptor reflex activity after xylazine (2-(2,6-dimethylphenylamino)-4-H-5,6-dihydro-1,3-thiazine) in anesthetized dogs
  European Journal of Pharmacology, 1973